Sign in

CIK 0001729427 · Non-accelerated filer<br>Smaller reporting company

CNS Pharmaceuticals, Inc.

Sign in to watch
Ticker
CNSP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
operating
EIN
822318545
Phone
1-800-946-9185
Business address
2100 WEST LOOP SOUTH, SUITE 900, HOUSTON, TX, 77027
  1. 8-K Event Delisting notice
  2. SC 13G/A Stake Amended Statement of Ownership
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market buy Director bought 33,333 shares at $0.30 ($10,000)
  5. 4 Open-market buy Director bought 33,333 shares at $0.30 ($10,000)
  6. 4 Open-market buy Chief Financial Officer bought 66,666 shares at $0.30 ($20,000)
  7. 4 Open-market buy Chief Executive Officer bought 166,666 shares at $0.30 ($50,000)
  8. 3 Insider Initial Statement of Ownership
  9. 8-K Event Material agreement · Executive or director change
  10. 424B4 Offering Prospectus
  11. EFFECT Other Notice of Effectiveness
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. 8-K Event Executive or director change
  19. S-1/A Offering Registration Statement
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 8 of 20 · 390 filings